戻る
Enlivex Ltd (ENLV) 収入
ENLV 株価推移チャート
ENLV 収入
Enlivex Ltd
$0.9
-14.28%
$-0.15
終値： Mar 30, 16:00:00 GMT-4
$0.92
2.22%
$0.02
アフターマーケット：Mar 30, 20:00:00 GMT-4
主要データ
前終値
$1.05
始値
$1.01
当日レンジ
$0.8743 - $1.02
52週レンジ
$0.66 - $2.1
取引高
372.6K
平均取引高
352.8K
配当利回り
--
1株当たり利益(TTM)
-0.55
時価総額
$218.3M
ENLVとは何ですか？
Enlivex Therapeutics Ltd. engages in the development of macrophage reprogramming immunotherapy products. AllocetraTM is a therapy designed to reprogram macrophages into their homeostatic state. Diseases such as solid cancers, sepsis, COVID-19 and many others reprogram macrophages out of their homeostatic state. These non-homeostatic macrophages contribute significantly to the severity of the respective diseases. By restoring macrophage homeostasis, AllocetraTM has the potential to provide immunotherapeutic mechanism of action for life-threatening clinical indications that are defined as unmet medical needs, as a stand-alone therapy or in combination with therapeutic agents.